Reuters - Biotechnology company Amgen Inc. said on Monday that the U.S. Food and Drug Administration has agreed to a "priority review" of the company's application for experimental drug panitumumab as a treatment for colon cancer.

Reuters - Amgen Inc. said on Sunday that early results from mid-stage trials of its experimental drug denosumab show that it works at least as well as current therapies to limit bone loss in patients with late-stage cancer.

Reuters - Amgen Inc. on Tuesday said its first-quarter profit rose 17 percent on increased sales of its drugs to treat anemia and arthritis.

Reuters - Biotechnology company Amgen Inc. said on Tuesday it is asking the U.S. government to ban imports of Roche Holding AG's experimental anemia drug Cera, saying it infringes on a patent for Amgen's own anemia treatment.

Guess who's sponsoring the bike Tour of California? Amgen, the company behind the banned performance-enhancer. Fans are more amused than outraged. By Bryan Ball.